The scalable foneDx technology is a monitoring solution for cardiovascular and pulmonary health that can be used with a user’s smartphone. It makes use of the built-in sensors found in smartphones in addition to a custom user interface application.
According to the company, this is the first integrated digital monitoring solution in the world and is available for use by commercial organizations, healthcare providers, and patients. A user’s vital heart and lung health can be measured at home with the help of the digital monitoring solution. By doing this, electronRx seeks to enhance clinical results and enable patients and medical professionals to manage chronic illnesses more skillfully.
“Our mission is to deliver a democratised and scalable smartphone technology that will use critical digital monitoring in pulmonary and cardiovascular to monitor patient health…” stated Bipin Patel, CEO of electronRx.
“I believe we have created something incredible that could turn millions of smartphones worldwide into efficient, effective and life-saving health monitors that will improve millions of people’s lives through better condition management leading to better, life-saving clinical outcomes. This will change how we think of areas of healthcare, forever.”
Healthcare providers will find the real-time data collection to be extremely valuable. Attendees at CES 2024 will be able to test out foneDx and its features firsthand thanks to electronRx’s technology launch.